levobupivacaine bolus dosing — Competitive Intelligence Brief

levobupivacaine bolus dosing (levobupivacaine bolus dosing) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia/Pain Management.

marketed Local anesthetic (amide) Voltage-gated sodium channels Anesthesia/Pain Management Small molecule

Target snapshot

levobupivacaine bolus dosing (levobupivacaine bolus dosing) — Kuopio University Hospital. Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
levobupivacaine bolus dosing TARGET	levobupivacaine bolus dosing	Kuopio University Hospital	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Levobupivacaine and Fentanyl	Levobupivacaine and Fentanyl	Hamad Medical Corporation	marketed	Local anesthetic with opioid analgesic combination	Voltage-gated sodium channels; mu-opioid receptor
lidocaine with propofol	lidocaine with propofol	Imam Abdulrahman Bin Faisal University	marketed	Local anesthetic and sedative-hypnotic combination	Voltage-gated sodium channels (lidocaine); GABA-A receptors (propofol)
Lidocaine 2% Injectable Solution	Lidocaine 2% Injectable Solution	Erasme University Hospital	marketed	Local anesthetic	Voltage-gated sodium channels
Lidocaine plus adrenaline	Lidocaine plus adrenaline	University of Santiago de Compostela	marketed	Local anesthetic with vasopressor	Voltage-gated sodium channels; alpha-1 and beta-1 adrenergic receptors
Lidocaine 2% Jelly	Lidocaine 2% Jelly	Hermann Eye Center	marketed	Local anesthetic	Voltage-gated sodium channels
lignocaine+dexamethasone	lignocaine+dexamethasone	Aligarh Muslim University	marketed	Local anesthetic + corticosteroid combination	Voltage-gated sodium channels (lignocaine); glucocorticoid receptor (dexamethasone)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

1. Poznan University of Medical Sciences · 4 drugs in this class
2. Nantes University Hospital · 3 drugs in this class
3. Bozyaka Training and Research Hospital · 2 drugs in this class
4. ASST Gaetano Pini-CTO · 2 drugs in this class
5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
6. Chiang Mai University · 1 drug in this class
7. Beijing Tiantan Hospital · 1 drug in this class
8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
10. China Medical University, China · 1 drug in this class